Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 40/73 ]
NASDAQ | Common Stock
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
The company operates in two segments, CooperVision and CooperSurgical.
The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia.
Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage.
This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing.
The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers.
The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Dec 4, 25 | 1.15 Increased by +10.58% | 1.11 Increased by +3.60% |
| Aug 27, 25 | 1.10 Increased by +14.58% | 1.07 Increased by +2.80% |
| May 29, 25 | 0.96 Increased by +12.94% | 0.93 Increased by +3.23% |
| Mar 6, 25 | 0.92 Increased by +8.24% | 0.91 Increased by +1.10% |
| Dec 5, 24 | 1.04 Decreased by -70.03% | 1.00 Increased by +4.00% |
| Aug 28, 24 | 0.96 Decreased by -71.34% | 0.91 Increased by +5.49% |
| May 30, 24 | 0.85 Decreased by -72.40% | 0.83 Increased by +2.41% |
| Feb 29, 24 | 0.85 Decreased by -70.69% | 0.78 Increased by +8.97% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Oct 31, 25 | 1.07 B Increased by +4.60% | 84.60 M Decreased by -28.00% | Increased by +7.94% Decreased by -31.16% |
| Jul 31, 25 | 1.06 B Increased by +5.73% | 98.30 M Decreased by -6.11% | Increased by +9.27% Decreased by -11.20% |
| Apr 30, 25 | 1.00 B Increased by +6.33% | 87.70 M Decreased by -1.35% | Increased by +8.75% Decreased by -7.23% |
| Jan 31, 25 | 964.70 M Increased by +3.55% | 104.30 M Increased by +28.45% | Increased by +10.81% Increased by +24.04% |
| Oct 31, 24 | 1.02 B Increased by +9.85% | 117.50 M Increased by +39.05% | Increased by +11.54% Increased by +26.59% |
| Jul 31, 24 | 1.00 B Increased by +7.80% | 104.70 M Increased by +22.74% | Increased by +10.44% Increased by +13.86% |
| Apr 30, 24 | 942.60 M Increased by +7.43% | 88.90 M Increased by +123.37% | Increased by +9.43% Increased by +107.92% |
| Jan 31, 24 | 931.60 M Increased by +8.51% | 81.20 M Decreased by -4.02% | Increased by +8.72% Decreased by -11.55% |